home / stock / rcel / rcel news

RCEL News and Press, Avita Medical Inc. From 02/21/24

Stock Information
Company Name: Avita Medical Inc.
Stock Symbol: RCEL
Market: NYSE
Website: avitamedical.com
Menu
RCEL RCEL Quote RCEL Short RCEL News RCEL Articles RCEL Message Board
Get RCEL Alerts

News, Short Squeeze, Breakout and More Instantly...
RCEL - AVITA Medical Q4 2023 Earnings Preview

2024-02-21 12:16:33 ET More on AVITA Medical AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS Avita Medical misses Q4, FY23 prelim revenue estimate Seeking ...
RCEL - AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

VALENCIA, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced that it will report its fourth quarter and f...

RCEL - Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS

2024-01-21 16:50:33 ET More on Pacific Biosciences of California, AVITA Medical, etc. AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum Pacific Biosciences' Revio And Onso Lead Looks Priced In For Now Reassessing Pacific Biosciences: Deep...

RCEL - When the Price of (RCEL) Talks, People Listen

2024-01-21 16:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
RCEL - AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced it has entered...

RCEL - Avita Medical misses Q4,FY 23 prelim revenue estimate

2024-01-10 09:20:18 ET More on AVITA Medical AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum AVITA Medical, Inc. (RCEL) Q3 2023 Earnings Call Transcript AVITA Medical's Recell Go Hits A Stoplight Avita Medical cuts 2023 commerci...

RCEL - AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced preliminary un...
RCEL - AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

VALENCIA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced that Jim Corbett, Chief Executive Officer, w...

RCEL - How the (RCEL) price action is used to our Advantage

2023-12-23 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RCEL - AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum

2023-12-19 20:38:32 ET Summary AVITA Medical's Spray-On Skin Cells device rapidly processes a patient's own skin to treat large dermatological injuries. The company's sales growth is expected to accelerate in 2024 due to the supplement of its RECELL System for full-thickness skin ...
Previous 10 Next 10